| Toll-Like Receptor 2 (TLR2) Polymorphisms Are Associated with Reversal Reaction in Leprosy PY Bochud, TR Hawn, MR Siddiqui, P Saunderson, S Britton, I Abraham, ... The Journal of infectious diseases 197 (2), 253-261, 2008 | 181 | 2008 |
| The missing millions: a threat to the elimination of leprosy WC Smith, W van Brakel, T Gillis, P Saunderson, JH Richardus PLoS neglected tropical diseases 9 (4), e0003658, 2015 | 175 | 2015 |
| Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15 E Cambau, P Saunderson, M Matsuoka, ST Cole, M Kai, P Suffys, ... Clinical Microbiology and Infection 24 (12), 1305-1310, 2018 | 153 | 2018 |
| The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome P Saunderson, S Gebre, K Desta, P Byass, DN Lockwood Lepr Rev 71 (3), 285-308, 2000 | 143 | 2000 |
| An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda PR Saunderson Social science & medicine 40 (9), 1203-1212, 1995 | 129 | 1995 |
| Social stigma: a comparative qualitative study of integrated and vertical care approaches to leprosy S Arole, R Premkumar, R Arole, M Maury, P Saunderson Leprosy review 73 (2), 186-196, 2002 | 120 | 2002 |
| Multidrug therapy for leprosy: a game changer on the path to elimination CS Smith, A Aerts, P Saunderson, J Kawuma, E Kita, M Virmond The Lancet Infectious Diseases 17 (9), e293-e297, 2017 | 117 | 2017 |
| ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors P Saunderson, S Gebre, P Byass Leprosy review 71 (3), 318-324, 2000 | 109 | 2000 |
| The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the … M Matsuoka, T Budiawan, KS Aye, K Kyaw, EV Tan, ED Cruz, R Gelber, ... Leprosy review 78 (4), 343-352, 2007 | 103 | 2007 |
| Nerve damage in leprosy: a continuing challenge to scientists, clinicians and service providers DN Lockwood, PR Saunderson International health 4 (2), 77-85, 2012 | 102 | 2012 |
| Analysis of Antibody Responses to Mycobacterium leprae Phenolic Glycolipid I, Lipoarabinomannan, and Recombinant Proteins To Define Disease Subtype … JS Spencer, HJ Kim, WH Wheat, D Chatterjee, MV Balagon, RV Cellona, ... Clinical and Vaccine Immunology 18 (2), 260-267, 2011 | 100 | 2011 |
| Factors associated with impairments in new leprosy patients: the AMFES cohort A Meima, PR Saunderson, S Gebre, K Desta, GJ Van Oortmarssen, ... Lepr Rev 70 (2), 189-203, 1999 | 97 | 1999 |
| Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy PY Bochud, D Sinsimer, A Aderem, MR Siddiqui, P Saunderson, S Britton, ... European journal of clinical microbiology & infectious diseases 28, 1055-1065, 2009 | 94 | 2009 |
| Delay in presentation and start of treatment in leprosy patients: a case-control study of disabled and non-disabled patients in three different settings in Ethiopia W Bekri, S Gebre, A Mengiste, PR Saunderson, S Zewge International journal of leprosy and other mycobacterial diseases 66 (1), 1-9, 1998 | 94 | 1998 |
| Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial RO Phillips, J Robert, KM Abass, W Thompson, FS Sarfo, T Wilson, ... The Lancet 395 (10232), 1259-1267, 2020 | 87 | 2020 |
| Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy JS Spencer, MS Duthie, A Geluk, MF Balagon, HJ Kim, WH Wheat, ... Memórias do Instituto Oswaldo Cruz 107, 79-89, 2012 | 83 | 2012 |
| The epidemiology of reactions and nerve damage P Saunderson Lepr rev 71 (Suppl), S106-10, 2000 | 82 | 2000 |
| Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme JH Richardus, A Tiwari, T Barth-Jaeggi, MA Arif, NL Banstola, R Baskota, ... The Lancet Global Health 9 (1), e81-e90, 2021 | 75 | 2021 |
| Neuropathic pain in people treated for multibacillary leprosy more than ten years previously P Saunderson, E Bizuneh, R Leekassa Leprosy review 79 (3), 270-276, 2008 | 69 | 2008 |
| Relapses after fixed duration multiple drug therapy: the AMFES cohort. S Gebre, P Saunderson, P Byass Leprosy review 71 (3), 325-331, 2000 | 63 | 2000 |
